Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SAT1 | P21673 | 1/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 10/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 9/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12662968 | 0.94 | ALDH1A1 (0.42) | SAT1LPAR3LPAR2LPAR1ALDH1A1 | |
| SCHEMBL21553512 | 0.93 | SAT1 (0.41) | SAT1LPAR3LPAR2LPAR1 | |
| SCHEMBL16815002 | 0.87 | LPAR3 (0.56) | SAT1LPAR3LPAR2LPAR1ALDH1A1 | |
| SCHEMBL16815019 | 0.87 | LPAR3 (0.56) | SAT1LPAR3LPAR2LPAR1ALDH1A1 | |
| SCHEMBL16815020 | 0.87 | LPAR3 (0.56) | SAT1LPAR3LPAR2LPAR1ALDH1A1 | |
| SCHEMBL16919757 | 0.86 | SAT1 (0.44) | SAT1LPAR3LPAR2LPAR1ALDH1A1 | |
| SCHEMBL12914742 | 0.84 | SAT1 (0.57) | SAT1LPAR3LPAR2LPAR1ALDH1A1 | |
| SCHEMBL17309416 | 0.81 | SAT1 (0.33) | SAT1LPAR3LPAR2LPAR1 | |
| SCHEMBL16919756 | 0.80 | ALDH1A1 (0.52) | SAT1LPAR3LPAR2LPAR1ALDH1A1 | |
| SCHEMBL13117333 | 0.80 | LPAR3 (0.68) | SAT1LPAR3LPAR2LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11821026-B2 | Chemical compositions and methods of using same | NANOSTRING TECHNOLOGIES, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-20230366012-A1 | CHEMICAL COMPOSITIONS AND METHODS OF USING THE SAME | BRUKER SPATIAL BIOLOGY, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230220461-A1 | CHEMICAL COMPOSITIONS AND METHODS OF USING SAME | BRUKER SPATIAL BIOLOGY, INC. | 2023-07-13 | — | — | US | disclosed |
| US-20180142286-A1 | CHEMICAL COMPOSITIONS AND METHODS OF USING SAME | BRUKER SPATIAL BIOLOGY, INC. | 2018-05-24 | — | — | US | disclosed |
| US-9783804-B2 | Compositions and methods for inhibition of nucleic acids function | Life Technologies Corporation (US) | 2017-10-10 | — | — | US | disclosed |
| US-20170009232-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | Life Technologies Corporation | 2017-01-12 | — | — | US | disclosed |
| US-9410153-B2 | Compositions and methods for inhibition of nucleic acids function | Life Technologies Corporation (US) | 2016-08-09 | — | — | US | disclosed |
| US-9145556-B2 | Compositions and methods for inhibition of nucleic acids function | Life Technologies Corporation (US) | 2015-09-29 | — | — | US | disclosed |
| US-20150166992-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | Life Technologies Corporation (US) | 2015-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170009232-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEIC ACIDS FUNCTION | RNGTT, NSUN3, NSUN2 | SAT1 2634/4885LPAR3 1002/4885LPAR2 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.